Cayston

Aztreonam

5.5 Moderate risk

Cayston & Infective pulmonary exacerbation of cystic fibrosis

11.9%

of users reported Infective pulmonary exacerbation of cystic fibrosis

58.1%

also reported Severe reaction

52.2%

are women

Most common medical consequences

Severe reaction

58.1%

Hospitalization

41.9%

Have you experienced any negative side effects from this medication?

Cayston: general information

Most common side effects (21)

Most commonly affected ages

0 - 9 years

4.2%

10 - 19 years

26.4%

20 - 29 years

25.6%

30 - 39 years

24.0%

40 - 49 years

2.6%

50 - 59 years

3.4%

60 - 69 years

<0.1%

70 - 79 years

13.8%

On this page